skip to main content
Idioma:
Resultados 1 2 3 4 next page
Refinado por: assunto: Hiv remover assunto: Infectious Diseases remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
(1–3)-Beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients
(1–3)-Beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

(1–3)-Beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients

Esteves, F. ; Lee, C.-H. ; de Sousa, B. ; Badura, R. ; Seringa, M. ; Fernandes, C. ; Gaspar, J. F. ; Antunes, F. ; Matos, O.

European journal of clinical microbiology & infectious diseases, 2014-07, Vol.33 (7), p.1173-1180 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
2
Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results
Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results

Gatell, Jose ; Ceron, Dominique Salmon ; Lazzarin, Adriano ; Wijngaerden, Eric Van ; Antunes, Francisco ; Leen, Clifford ; Horban, Andrzej ; Wirtz, Victoria ; Odeshoo, Linda ; Dungen, Monique Van den ; Gruber, Claudia ; Ledesma, Emilio

Clinical infectious diseases, 2007-06, Vol.44 (11), p.1484-1492 [Periódico revisado por pares]

Chicago, IL: The University of Chicago Press

Texto completo disponível

Citações Citado por
3
AIDS across Europe, 1994–98: the EuroSIDA study
AIDS across Europe, 1994–98: the EuroSIDA study
Material Type:
Artigo 		Adicionar ao Meu Espaço

AIDS across Europe, 1994–98: the EuroSIDA study

Mocroft, A ; Katlama, C ; Johnson, AM ; Pradier, C ; Antunes, F ; Mulcahy, F ; Chiesi, A ; Phillips, AN ; Kirk, O ; Lundgren, JD

The Lancet (British edition), 2000-07, Vol.356 (9226), p.291-296 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
Material Type:
Artigo 		Adicionar ao Meu Espaço

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

Soriano, Vincent ; Mocroft, Amanda ; Peters, Lars ; Rockstroh, Juergen ; Antunes, Francisco ; Kirkby, Nikolai ; de Wit, Stephane ; Monforte, Antonella d'Arminio ; Flisiak, Robert ; Lundgren, Jens

Journal of antimicrobial chemotherapy, 2010-03, Vol.65 (3), p.548-555 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
5
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

Yeni, P ; Cooper, D A ; Aboulker, J P ; Babiker, A G ; Carey, D ; Darbyshire, J H ; Floridia, M ; Girard, P M ; Goodall, R L ; Hooker, M H ; Mijch, A ; Meiffredy, V ; Salzberger, B

The Lancet (British edition), 2006-07, Vol.368 (9532), p.287-298 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii
Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii

Esteves, F ; Tavares, A ; Costa, M. C ; Gaspar, J ; Antunes, F ; Matos, O

European journal of clinical microbiology & infectious diseases, 2009-02, Vol.28 (2), p.175-178 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por
7
Hepatitis delta in HIV-infected individuals in Europe
Hepatitis delta in HIV-infected individuals in Europe
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hepatitis delta in HIV-infected individuals in Europe

SORIANO, Vincent ; CRINT, Daniel ; PETERS, Lars ; D'ARMINIO MONFORTE, Antonella ; HORBAN, Andrzej ; LEEN, Clifford ; POVEDA, Eva ; ANTUNES, Francisco ; DE WIT, Stephane ; LUNDGREN, Jens ; ROCKSTROH, Juergen

AIDS (London), 2011-10, Vol.25 (16), p.1987-1992 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
8
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Eron, Joseph J, Prof ; Young, Benjamin, MD ; Cooper, David A, Prof ; Youle, Michael, MD ; DeJesus, Edwin, MD ; Andrade-Villanueva, Jaime, MD ; Workman, Cassy, MD ; Zajdenverg, Roberto, MD ; Fätkenheuer, Gerd, Prof ; Berger, Daniel S, MD ; Kumar, Princy N, MD ; Rodgers, Anthony J, MS ; Shaughnessy, Melissa A, MS ; Walker, Monica L, BS ; Barnard, Richard JO, PhD ; Miller, Michael D, PhD ; DiNubile, Mark J, MD ; Nguyen, Bach-Yen, MD ; Leavitt, Randi, MD ; Xu, Xia, PhD ; Sklar, Peter, Dr

The Lancet (British edition), 2010-01, Vol.375 (9712), p.396-407 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

KATLAMA, Christine ; HAUBRICH, Richard ; WOODFALL, Brian ; DE SMEDT, Goedele ; LALEZARI, Jacob ; LAZZARIN, Adriano ; MADRUGA, José V ; MOLINA, Jean-Michel ; SCHECHTER, Mauro ; PEETERS, Monika ; PICCHIO, Gaston ; VINGERHOETS, Johan

AIDS (London), 2009-11, Vol.23 (17), p.2289-2300 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
10
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease

BORGES, Alvaro H ; LUNDGREN, Jens D ; GARGALIANOS, Panagiotis ; MOCROFT, Amanda ; RIDOLFO, Annalisa ; KATLAMA, Christine ; ANTUNES, Francisco ; GRZESZCZUK, Anna ; BLAXHULT, Anders ; MITSURA, Viktar M ; DOROANA, Manuela ; BATTEGAY, Manuel

AIDS (London), 2014-11, Vol.28 (17), p.2565-2571 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1999  (4)
  2. 1999Até2003  (7)
  3. 2004Até2007  (4)
  4. 2008Até2011  (14)
  5. Após 2011  (12)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.